Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Sam H. Ahmedzai
Sam is Emeritus Professor at the University of Sheffield, UK with 30 years’ experience as consultant physician in palliative medicine, covering both acute hospital and hospice. His interests cover: supportive care at all stages of cancer and chronic illness; cancer-related pain and opioid drugs; symptom management in advanced diseases and at the end of life; quality of life and holistic needs assessment; and patient and public involvement in cancer research.
Sam is National Institute for Health Research (NIHR) National Specialty Lead for cancer research with a specific brief for supportive care and hospice research. He chairs the National Cancer Research Institute (NCRI) Clinical Studies Group on Supportive and Palliative Care. He also works with the National Institute for Health and Clinical Excellence (NICE) on producing UK guidelines, quality standards and technology appraisals relevant to supportive and palliative care.
In 2016 Sam was given the Lifetime Achievement Award by the British Thoracic Oncology Group. He is an elected member of the Council of the British Pain Society and has been awarded Honorary Fellowship of the Faculty of Pain Medicine in the Royal College of Anaesthetists. He is Visiting Spinoza Professor at the University of Amsterdam, Netherlands.
Magnus Ekström, MD, is a consultant and Associate professor in Respiratory Medicine at Lund University, Sweden, and head of the Swedish National Registry for Respiratory Failure (Swedevox). His main research focus is contributing factors, measurement and treatment of breathlessness. He also leads research in oxygen therapy and treatment in patients with chronic respiratory failure. He is involved in multiple multicenter studies and international research collaborations, and lead projects across a range of research methodologies, including mechanistic, epidemiological and registry-based studies, clinical cohort studies, Cochrane meta-analyses, and randomized controlled trials.
Dr Lynn Calman is a Principal Research Fellow and Deputy Director of the Macmillan Survivorship Research Group (MSRG) at the Faculty of Health Sciences, University of Southampton, UK. Lynn undertook a BSc (Hons) in Nursing (Adult) at the University of Edinburgh, UK and worked clinically in palliative care and completed training as a mental health nurse before undertaking her doctorate at the University of Edinburgh. Lynn has held academic positions at the Universities of Glasgow and Manchester, UK, before taking up her role in Southampton in 2012. She was awarded an MRC Postdoctoral Fellowship in Health Services Research 2008–2012 to explore how lung cancer patients can be supported to live well after treatment.
Lynn has led and collaborated on a number of major research studies in cancer survivorship and psychosocial oncology. Currently she is a co-applicant on the Macmillan Cancer Support funded five-year HORIZONS Programme, designed to understand recovery and wellbeing following curative intent cancer treatment and inform the development of more efficient and effective services to support survivors. She is also leading her own research programme focusing on people living with cancer that cannot be cured. Since 2016, Lynn has been a member of the National Cancer Research Institute (NCRI) Lung Cancer Clinical Studies Group (CSG) and until 2017 was member of the Psychosocial Oncology and Survivorship CSG and Chaired the subgroup: Understanding and measuring the consequences of cancer and its treatment.
Dr Natasha Campling is a Senior Research Fellow within the Faculty of Health Sciences, University of Southampton, UK. She is a nurse by background, having qualified at the University of Edinburgh, UK with a first-class degree (BSc Hons), before going on to specialize in cancer and palliative care at the Royal Marsden Hospital, London. In 2006 Natasha completed a PhD in Nursing from King's College London funded by an EPSRC doctoral training award. Since then she has worked as an academic researcher and has held positions at King's College London, the School of Pharmacy (University of London), and Cranfield University; managing and leading the delivery of an extensive range of research studies. Recently she has focused exclusively on research in palliative and end-of-life care, collaborating on a study funded by the Health Technology Assessment programme of the National Institute of Health Research (NIHR) on Self-Management of Analgesia and Related Treatments at the end-of-life. Natasha led the qualitative components of the study, including design, data collection, and analysis. Following this, Natasha focused on two end-of-life areas. First, a project supporting family caregivers at end-of-life, funded by the NIHR's School for Social Care Research, which implemented evidence to support family caregivers in the transition between hospital and home. Second, a programme of work exploring treatment decisions in the face of patient deterioration in hospital: development and implementation of treatment escalation plans, funded by NIHR CLAHRC (Collaboration for Leadership in Applied Health Research and Care) Wessex. Currently Natasha is conducting a mixed method evaluation of service provision for accessing medicines at end of life (ActMed) funded by the Health Services and Delivery Research programme of the NIHR, for which she is a co-applicant.
Fred Saad, MD, FRCS is Professor and Chairman of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM), Canada. He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group. Dr Saad has been involved in most of the important clinical trials in advanced prostate cancer over the last 20 years and presently sits on 7 steering committees of international clinical trials. He serves on several international guidelines committees and sits on 7 editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology, and Urology, as well as Current Oncology. He has published over 400 peer-reviewed articles as well as over 1,500 scientific abstracts, 8 books and over 50 book chapters. With a h-factor of 96 and over 41,000 citations he was listed as one of the most cited scientists in 2017. Dr Saad's research interests include molecular prognostic markers, mechanisms of progression, and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing and has received over 30 million dollars in research grants to date. In 2014 he received the lifetime achievement award from the CHUM Research Center and in 2017 received the outstanding contribution award from The Prostate Cancer Canada Network.
Roberto Casale MD, PhD graduated in Medicine and Surgery from Pavia University, Italy in 1975. He became full board certified in Physical Medicine and Rehabilitation at Pavia University in 1976, and also specialized in neurology with a postgraduate course in Clinical Neurophysiology. He specialised in anesthesiology and pain relief in 1989 and obtained a PhD in Advanced Technologies in Rehabilitation and Sports from the University of Rome Tor Vergata, Rome, Italy.
Dr Casale is Scientific Director at Habilita Care and Research Rehabilitation Hospitals, Bergamo, Italy. He is the Director of the EFIC (European Pain Federation) Pain School on Neuropathic Pain, formerly known as EFIC Montescano Pain School and now moved to Bergamo (EFIC Bergamo Neuropathic Pain School). Currently, he is also the Chairman of the ESPRM (European Society of Physical and Rehabilitation Medicine) SIG on ‘Pain and Disability’.
Dr Casale has lectured at University Schools of Specialization in Pavia, Padua, Florence and Siena. From 1992 to 2015, he was Director of the Department of Clinical Neurophysiology and Pain Rehabilitation Unit. From 2001 to 2015, he was the Director of the Department of Neuromotor Rehabilitation at the Salvatore Maugeri Foundation, Scientific Institute of Montescano, Italy. He was also in charge of the Alzheimer Unit from 1999 to 2015. He has been Councillor and Secretary of AISD (Italian Association for the Study of Pain), as well as Councillor of EFIC (European Chapters of IASP), and Co-ordinator of the SIG ‘Pain and Rehabilitation’ of SIMFER (Italian Association of Physical Medicine and Rehabilitation). His scientific interests are: pain medicine (physiopathology of pain and pain therapy, muscle pain, neuropathic pain, CRPS, microneurography), and rehabilitation medicine (chronic pain and associated motor disability, central and peripheral nervous system lesions, localized muscle fatigue).